Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001412071-26-000004

Options or other derivatives

  • President and CEO acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Singh Shawn President and CEO 2026-04-07 Grant or award · Incentive Stock Option (right to buy) +3,732 3,732 D
Singh Shawn President and CEO 2026-04-07 Grant or award · Non-Qualified Stock Option (right to buy) +71,268 71,268 D
Loading xslF345X06/edgardoc.xml…